Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending August 5, 2022

Drug Industry TRx: +7.2% w/w; +11.1% y/y

Vascepa
TRx 66,024; +5.9% (+3,692) w/w; -20.8% y/y
NRx 29,736; +5.3% (+1,508) w/w; -19.4% y/y
Ref 36,287; +6.4% (+2,184) w/w; -22.0% y/y

Lovaza (Fake & Brand)
TRx 65,147; +5.8% (+3,587) w/w; +3.1% y/y
NRx 32,200; +8.0% (+2,376) w/w; +7.5% y/y
Ref 32,946; +3.8% (+1,202) w/w; -0.9% y/y

Fake Vascepa
TRx 40,549; +7.2% (+2,732) w/w; As % of total V: 38.0%
NRx 20,280; +9.3% (+1,722) w/w; As % of total V: 40.5%
Ref 20,269; +5.2% (+1,010) w/w; As % of total V: 35.8%

Fake Vascepa by Manufacturer
Hikma - TRx 13,492; (+802) w/w; Generic share 33.3%; Total V share 12.7%
Reddy - TRx 20,260; (+2,122) w/w; Generic share 50.0%; Total V share 19.0%
Apotex - TRx 6,796; (-193) w/w; Generic share 16.8%; Total V share 6.4%

Vascepa + Fake Vascepa
TRx 106,572; +6 4% (+6,424) w/w; +8.2% y/y
NRx 50,016; +6.9% (+3,229) w/w; +10.2% y/y
Ref 56,555; +6.0% (+3,194) w/w; +6.4% y/y